Drug Approval | April 20, 2026
Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
PMDA is regarded among the most stringent regulatory bodies globally
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The conclave brought together over 1,000 delegates from across India and internationally
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
Subscribe To Our Newsletter & Stay Updated
